Vera E. Van Der Noord
Leiden, ZH 2333CC, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 02, 2025
Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy.
Journal: Journal of medicinal chemistry
Published: June 26, 2024
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 14, 2023
Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors.
Journal: Breast cancer research : BCR
Published: January 16, 2023
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia.
Journal: Breast cancer research and treatment
Published: October 28, 2022
Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery.
Journal: Cancers
Published: August 10, 2022
Development of a Retinal-Based Probe for the Profiling of Retinaldehyde Dehydrogenases in Cancer Cells.
Journal: ACS central science
Published: October 07, 2019
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer.
Journal: Breast cancer research and treatment
Published: February 21, 2019
A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy.
Journal: Breast cancer research : BCR
Published: October 05, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026